Buy Recommendation Issued On GANX By Roth Capital

December 19, 2025 01:15:03 pm

Source: KlickAnalytics

2025-12-19 13:15:03 ET

Roth Capital analyst issues BUY recommendation for GANX on December 19, 2025 06:34PM ET.

The previous analyst recommendation was Buy.

GANX was trading at $2.66 at issue of the analyst recommendation.

The overall analyst consensus : BUY.

Current analyst recommendations are : 7 - Buy, 1 - Hold recommendations .

Latest 10 recommendations
< ...
Full story available on KlickAnalytics.com

Gain Therapeutics Inc.

0.0% G/L:

$1.935 Last:

402,424 Volume:

$1.90 Open:

March 19, 2026 04:57:09 pm

March 18, 2026 08:15:00 am

March 12, 2026 07:00:00 am

February 19, 2026 07:00:00 am

Market Cap $88,106,499

Float 46,203,645

Insiders Ownership 0.36%

Institutions 12

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Bethesda